TheRyte Overview

  • Founded
  • 1998
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

TheRyte General Information


Provider of cancer therapeutic devices and drugs designed to revolutionize cancer treatments. The company is engaged in creating treatments that target the processes that normally stabilize the cancer cell and developing biomarkers to predict treatment response, enabling patients to recover faster.

Contact Information

Formerly Known As
Earthmetal, Bioclin
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Primary Office
  • William Russell House
  • The Square, Surrey
  • Lightwater GU18 5SS
  • England, United Kingdom
+44 01276 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TheRyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 16-Jan-2018 00000 Completed Out of Business
4. Grant 14-Nov-2011 000.00 00000 Completed Generating Revenue
3. Later Stage VC 15-Sep-2011 00000 Completed Generating Revenue
2. Later Stage VC 10-Sep-2008 $455K $455K Completed Generating Revenue
1. Later Stage VC Completed Generating Revenue
To view TheRyte’s complete valuation and funding history, request access »

TheRyte Patents

TheRyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110158956-A1 Treating cancer Granted 11-Mar-2008 0000000000
GB-0804496-D0 Treating cancer Ceased 11-Mar-2008 0000000000
US-8883718-B2 Treating cancer Expired - Fee Related 11-Mar-2008 0000000000 0
EP-2260098-A1 Treating cancer Withdrawn 11-Mar-2008 0000000000
DE-60325579-D1 Cancer treatment Active 25-Mar-2002 G01N33/5011
To view TheRyte’s complete patent history, request access »